Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

1.2K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.2K
RNA Editing02:23

RNA Editing

9.6K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.6K
Bipolar Disorder01:30

Bipolar Disorder

477
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
477
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

331
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
331
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

8.5K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.5K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

403
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
403

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ADAR Therapeutics as a New Tool for Personalized Medicine.

Genes·2025
Same author

Differential Epigenetic Changes in the Dorsal Hippocampus of Male and Female SAMP8 Mice: A Preliminary Study.

International journal of molecular sciences·2023
Same author

Human Mutated <i>MYOT</i> and <i>CRYAB</i> Genes Cause a Myopathic Phenotype in Zebrafish.

International journal of molecular sciences·2023
Same author

Genome-wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: Increased antibody levels and side effects in carriers of the HLA-A*03:01 allele.

HLA·2023
Same author

Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine.

International journal of molecular sciences·2023
Same author

Stress, microRNAs, and stress-related psychiatric disorders: an overview.

Molecular psychiatry·2023

Related Experiment Video

Updated: Dec 13, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.1K

RNA Editing and Modifications in Mood Disorders.

Alessandro Barbon1, Chiara Magri1

  • 1Section of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia; Viale Europa 11, 25123 Brescia, Italy.

Genes
|August 6, 2020
PubMed
Summary

This review explores RNA modifications, specifically adenosine to inosine (A-to-I) RNA editing and m6A methylation, as crucial factors in major depressive disorder (MDD) research. Understanding these epitranscriptomic changes offers new insights into MDD

Keywords:
ADAR1ADAR2RNA editingantidepressantdepressionm6a methylationmajor depressive disorderspsychiatric disorderstress

More Related Videos

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
13:08

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia

Published on: December 2, 2015

9.2K
Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
11:57

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Published on: April 21, 2016

6.9K

Related Experiment Videos

Last Updated: Dec 13, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.1K
Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
13:08

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia

Published on: December 2, 2015

9.2K
Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
11:57

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Published on: April 21, 2016

6.9K

Area of Science:

  • Molecular Psychiatry
  • Epitranscriptomics
  • Neuroscience

Background:

  • Major Depressive Disorder (MDD) is a leading cause of disability worldwide, with significant societal costs.
  • While genetic, epigenetic, and proteomic factors in MDD are well-studied, RNA modifications remain underexplored.
  • Epitranscriptomic changes, dynamic alterations to RNA molecules, significantly impact gene expression and cellular function.

Purpose of the Study:

  • To review current research on the role of RNA editing and m6A methylation in the molecular mechanisms of MDD.
  • To highlight the potential of epitranscriptomic alterations as novel targets for understanding and treating MDD.
  • To discuss the challenges and future directions in the study of RNA modifications in major depressive disorder.

Main Methods:

  • Literature review of studies investigating RNA editing (specifically A-to-I) and m6A methylation in MDD.
  • Synthesis of findings related to the impact of these RNA modifications on gene expression relevant to MDD.
  • Analysis of the current understanding and limitations of epitranscriptomic research in major depressive disorder.

Main Results:

  • Adenosine to inosine (A-to-I) RNA editing and m6A methylation represent key epitranscriptomic mechanisms.
  • Emerging evidence suggests these RNA modifications play a significant role in the pathophysiology of MDD.
  • These modifications add a new layer of complexity to gene expression regulation in the context of major depressive disorder.

Conclusions:

  • RNA editing and m6A methylation are critical epitranscriptomic modifications with potential implications for MDD.
  • Further research into these RNA alterations could uncover novel biomarkers and therapeutic strategies for major depressive disorder.
  • The field of epitranscriptomics offers promising avenues for advancing our understanding of MDD's molecular underpinnings.